ALLISON MOSER: Open Payments
NPI 1336539980 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$16,205 in 79 payments from 13 companies in 2025. Trend: 2023 $11,659 · 2024 $11,052 · 2025 $16,205
Speaker / faculty: $5,378Food & beverage: $4,590Consulting: $3,725Travel & lodging: $2,481Education: $32
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 14 | $5,171 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $3,732 |
| ABBVIE INC. | 20 | $3,667 |
| Mirum Pharmaceuticals, Inc. | 6 | $1,957 |
| Madrigal Pharmaceuticals | 4 | $333 |
| GlaxoSmithKline, LLC. | 1 | $250 |
| Novo Nordisk Inc | 4 | $221 |
| Boston Scientific Corporation | 2 | $210 |
| Gilead Sciences, Inc. | 6 | $192 |
| Mallinckrodt Hospital Products Inc. | 2 | $166 |
Products named: IQIRVO, MAVYRET, XIFAXAN, Livmarli, TRULANCE, Bylvay, REZDIFFRA, General - Biliary Devices.
Industry payments across IL — which companies pay providers there.
